Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists
Authors' conclusion
Although there are regional differences, respondents generally employ the recommended diagnostic tools, treatments, and a multidisciplinary approach suggested by current clinical practice guidelines. However, there were examples of deviations from current guidance from professional societies.
Study context
- Population
- Endocrinologists worldwide; management of Graves' disease (GD) complicated by moderate-to-severe thyroid eye disease (TED)
- Participants
- 1,252 participants85 countries
- Exposure
- Regional differences in management of GD complicated by moderate-to-severe TED
- Outcome
- Regional differences in diagnosis and treatment of GD with TED
Methodological detailsinternational, online survey of endocrinologists
- International
- Online survey of endocrinologists
Main finding
As reported in the abstract
Sodium selenite use, Europe
66.5%
Sodium selenite use, Oceania
60%
Observational data: associations, not effects.
Original publication
Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists. Thyroid. Published 28 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →